Medicus Pharma Ltd. (MDCX)Healthcare | Drug Manufacturers - General | West Conshohocken, United States | NasdaqCM
0.26 USD
-0.01
(-3.771%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.26 +0.00 (0.815%) ⇧ (Aug. 28, 2026, 6:50 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:40 a.m. EDT
The immediate outlook is severely clouded by a catastrophic collapse in share price, which has erased nearly 90% of the value since late last year. While the company boasts a 'strong buy' recommendation and a massive gap between the current price and analyst targets, these metrics are misleading in the context of a biopharma company with negative earnings, negative free cash flow, and a negative return on equity. The stock is currently trading well below its book value, suggesting the market has priced in a fundamental failure rather than a temporary setback. Furthermore, the lack of any dividend history confirms this is a pure speculative vehicle with no income floor. The recent price action shows a fragile recovery attempt that has already stalled, leaving the security in a precarious position where the gap between optimistic analyst consensus and harsh market reality creates significant execution risk. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.294696 |
| AutoARIMA | 0.294700 |
| MSTL | 0.322298 |
| AutoTheta | 0.367829 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 27% |
| H-stat | 15.47 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.177 |
| Excess Kurtosis | -1.29 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 16,281,642 |
| Forward P/E | -0.54 |
| Beta | -0.48 |
| Website | https://medicuspharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.87115383 |
| Address1 | 300 Conshohocken State Road |
| Address2 | Suite 200 |
| All Time High | 8.94 |
| All Time Low | 0.243 |
| Ask | 0.3406 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 1,610,840 |
| Average Daily Volume3 Month | 1,781,920 |
| Average Volume | 1,781,920 |
| Average Volume10Days | 1,610,840 |
| Beta | -0.482 |
| Bid | 0.1875 |
| Bid Size | 2 |
| Book Value | 0.033 |
| City | West Conshohocken |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.2577 |
| Current Ratio | 1.566 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.2712 |
| Day Low | 0.2554 |
| Display Name | Medicus Pharma |
| Ebitda Margins | 0.0 |
| Enterprise Value | 22,783,188 |
| Eps Current Year | -0.54 |
| Eps Forward | -0.48 |
| Eps Trailing Twelve Months | -2.36 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.3525 |
| Fifty Day Average Change | -0.094799995 |
| Fifty Day Average Change Percent | -0.26893616 |
| Fifty Two Week Change Percent | -87.11539 |
| Fifty Two Week High | 3.05 |
| Fifty Two Week High Change | -2.7923 |
| Fifty Two Week High Change Percent | -0.9155082 |
| Fifty Two Week Low | 0.243 |
| Fifty Two Week Low Change | 0.0146999955 |
| Fifty Two Week Low Change Percent | 0.06049381 |
| Fifty Two Week Range | 0.243 - 3.05 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,731,594,600,000 |
| Float Shares | 59,815,611 |
| Forward Eps | -0.48 |
| Forward P E | -0.536875 |
| Free Cashflow | -16,164,224 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 16 |
| Fullday Change | -0.0101 |
| Fullday Change Percent | -3.77147 |
| Fullday Price | 0.2598 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.111940004 |
| Held Percent Institutions | 0.041500002 |
| Implied Shares Outstanding | 63,180,610 |
| Industry | Drug Manufacturers - General |
| Industry Disp | Drug Manufacturers - General |
| Industry Key | drug-manufacturers-general |
| Ipo Expected Date | 2,024-11-14 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania. |
| Long Name | Medicus Pharma Ltd. |
| Market | us_market |
| Market Cap | 16,281,642 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_301013012 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -56,662,868 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 16,982,947 |
| Number Of Analyst Opinions | 4 |
| Open | 0.2662 |
| Operating Cashflow | -29,320,072 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 610 636 0184 |
| Post Market Change | 0.0020999908 |
| Post Market Change Percent | 0.8148975 |
| Post Market Price | 0.2598 |
| Post Market Time | 1,787,957,445 |
| Previous Close | 0.2678 |
| Price Eps Current Year | -0.4772222 |
| Price Hint | 4 |
| Price To Book | 7.8090906 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.4 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | -0.010100007 |
| Regular Market Change Percent | -3.771474 |
| Regular Market Day High | 0.2712 |
| Regular Market Day Low | 0.2553 |
| Regular Market Day Range | 0.2553 - 0.2712 |
| Regular Market Open | 0.2662 |
| Regular Market Previous Close | 0.2678 |
| Regular Market Price | 0.2577 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 578,519 |
| Return On Assets | -1.10674 |
| Return On Equity | -74.4611 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 63,180,610 |
| Shares Percent Shares Out | 0.044099998 |
| Shares Short | 2,788,116 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,838,930 |
| Short Name | Medicus Pharma Ltd. |
| Short Percent Of Float | 0.0463 |
| Short Ratio | 1.65 |
| Source Interval | 15 |
| State | PA |
| Symbol | MDCX |
| Target High Price | 9.0 |
| Target Low Price | 0.9 |
| Target Mean Price | 4.475 |
| Target Median Price | 4.0 |
| Total Cash | 15,174,128 |
| Total Cash Per Share | 0.24 |
| Total Debt | 21,636,986 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.36 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.84433 |
| Two Hundred Day Average Change | -0.58663 |
| Two Hundred Day Average Change Percent | -0.69478756 |
| Type Disp | Equity |
| Volume | 578,519 |
| Website | https://medicuspharma.com |
| Zip | 19,428 |